Related Experiment Videos
Pseudophakic malignant glaucoma: Nd:YAG capsulotomy as a primary treatment
1Moorfields Eye Hospital, London, UK.
Eye (London, England)
|January 1, 1993
Summary
Malignant glaucoma, a rare complication of anterior segment surgery, can be challenging to treat. Peripheral Nd:YAG posterior capsulotomy offers a minimally invasive option for pseudophakic eyes, successfully controlling pressure in many cases.
Area of Science:
- Ophthalmology
- Surgical Complications
Background:
- Malignant glaucoma is a rare but serious complication following anterior segment surgery.
- It is often refractory to medical management and has limited success with traditional surgical interventions.
Purpose of the Study:
- To evaluate the efficacy of peripheral Nd:YAG posterior capsulotomy as a treatment for malignant glaucoma in pseudophakic eyes.
- To assess its potential to avoid acute surgical intervention.
Main Methods:
- Retrospective case series of seven pseudophakic patients diagnosed with malignant glaucoma.
- Treatment involved peripheral Nd:YAG posterior capsulotomy to restore aqueous humor flow.
Main Results:
- Successful pressure control was achieved in five out of seven eyes following Nd:YAG posterior capsulotomy.
- This intervention obviated the need for immediate surgical management in the successful cases.
Conclusions:
- Peripheral Nd:YAG posterior capsulotomy is a viable and minimally invasive treatment option for malignant glaucoma in pseudophakic eyes.
- It can effectively re-establish anterior chamber pressure control and prevent the need for more invasive acute surgical procedures.